Saturday 31 October 2026
Export UHT’s income statement to Excel — free account
Universal Health Realty Income Trust
UHT Real Estate Reit Healthcare Facilities
Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024.
- Revenue
- +0.49%
- EPS
- +30.3%
- Free cash flow
- −69.3%
- Total debt
- +2.73%
Quarter to June 2026, against a year earlier
38.25
0.38
+1.00%
Follow UHT
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
31.55 | 31.37 | 30.63 | 29.90 |
+8 more quarters Free account |
P/S ratio |
6.11 | 5.65 | 5.46 | 5.45 | |
P/FCF ratio |
20.30 | 14.77 | 13.46 | 13.70 | |
P/Operating CF |
48.93 | 46.85 | 39.86 | 53.11 | |
P/B ratio |
4.22 | 3.79 | 3.56 | 3.42 | |
Price to Tangible BV |
4.37 | 3.93 | 3.69 | 3.55 | |
EV/Sales |
9.91 | 9.38 | 9.17 | 9.16 | |
EV/EBITDA |
15.22 | 14.48 | 14.17 | 14.08 | |
EV/Operating CF |
20.43 | 18.83 | 18.53 | 18.71 | |
EV/FCF |
32.90 | 24.55 | 22.60 | 23.02 | |
Quick Ratio |
5.54 | 6.14 | 6.05 | 7.37 | |
Current Ratio |
5.54 | 6.14 | 6.05 | 7.37 | |
Net Debt/EBITDA |
22.98 | 23.08 | 23.35 | 22.42 | |
Debt/Assets |
67.66% | 67.01% | 66.32% | 66.13% | |
Debt/Equity |
2.67 | 2.56 | 2.46 | 2.37 | |
Asset Turnover |
0.17 | 0.17 | 0.17 | 0.17 | |
Operating CF/Net income |
2.10 | 2.38 | 3.14 | 2.54 | |
Capex/Depreciation |
(1.23) | (0.60) | (0.49) | (0.20) | |
Interest Coverage |
2.07 | 2.01 | 1.83 | 1.74 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.81% | 0.77% | 1.12% | 0.93% | |
Graham Net Nets |
(0.55) | (0.58) | (0.60) | (0.59) | |
Graham Number |
18.03 | 17.61 | 17.82 | 18.39 | |
Earnings Yield |
3.17% | 3.19% | 3.26% | 3.34% | |
Free Cash Flow Yield |
4.93% | 6.77% | 7.43% | 7.30% | |
Revenue per Share |
1.81 | 1.77 | 1.77 | 1.83 | |
Operating CF per Share |
0.90 | 0.86 | 0.98 | 0.74 | |
Capex per Share |
(0.64) | (0.31) | (0.26) | (0.12) | |
Free Cash Flow per Share |
0.26 | 0.56 | 0.73 | 0.62 | |
Cash per Share |
0.49 | 0.51 | 0.48 | 0.50 | |
Shareholders Equity per Share |
10.40 | 10.68 | 11.03 | 11.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.40 | 10.68 | 11.03 | 11.47 | |
Free Cash Flow |
3.55 | 7.68 | 10.06 | 8.61 | |
Working Capital |
72.59 | 74.50 | 74.14 | 77.12 | |
Capital Expenditures |
(8.86) | (4.27) | (3.53) | (1.59) | |
Net Current Asset Value |
(334.65) | (326.95) | (323.69) | (320.23) | |
EV/EBIT |
28.07 | 26.83 | 26.17 | 25.62 | |
Capex to Sales |
0.35 | 0.17 | 0.14 | 0.06 | |
Price to Operating Income |
17.32 | 16.14 | 15.59 | 15.24 | |
| Other line items | |||||
Average Receivables |
82.11 | 82.29 | 82.47 | 82.62 | |
Average Assets |
570.07 | 568.62 | 572.88 | 576.18 | |
Average Common Equity |
154.53 | 159.98 | 165.96 | 170.11 |
Columns are period end dates